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Abstract
Objectives. Physiotherapy is recommended in the management of people with axial spondyloarthritis
(axSpA), with new insights into its preferred content and dosage evolving. The aim of this study was to de-
scribe the use and preferences regarding individual and group physiotherapy among people with axSpA.
Methods. A cross-sectional survey was conducted among people with axSpA living in The
Netherlands (NL) and Switzerland (CH).
Results. Seven hundred and thirteen people with axSpA participated (56.7% male, median age
55 years, median Assessment of Spondyloarthritis International Society Health Index score 4.2).
Response rates were 45% (n¼ 206) in NL and 29% in CH (n¼ 507). Of these participants, 83.3% were
using or had been using physiotherapy. Individual therapy only was used or had been used by 36.7%,
a combination of individual plus land- and water-based group therapy by 29.1% and group therapy by
only 5.3%. Fewer than half of the participants attending individual therapy reported active therapy
(such as aerobic, muscle strength and flexibility exercises). Although the majority (75.9%) were not
aware of the increased cardiovascular risk, participants showed an interest in cardiovascular training,
either individually or in a supervised setting. If supervised, a majority, in CH (75.0%) more than in NL
(55.7%), preferred supervision by a specialized physiotherapist.
Conclusion. The majority of people with axSpA use or have used physiotherapy, more often in an indi-
vidual setting than in a group setting. The content of individual therapy should be more active; in both
therapy settings, aerobic exercises should be promoted. In particular, enabling people with axSpA to per-
form exercises independently would meet their needs and might enhance their daily physical activity.
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Key messages
. The large majority of people with axial spondyloarthritis use physiotherapy.
. Individual physiotherapy in people with axial spondyloarthritis consists mainly of passive modalities.
. Many people with axial spondyloarthritis are unaware of increased cardiovascular risk but are interested in aerobic
exercise.
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Introduction
Axial spondyloarthritis (axSpA) is a chronic, inflammatory
rheumatic disease that affects the sacroiliac joints and
spine, leading to structural and activity limitations [1].
The prevalence in the general population is 0.1–0.6%
according to European disease prevalence data [2, 3].
Axial spondyloarthritis affects men and women equally
(1:1 ratio) [4]. Disease onset is usually in early adulthood
[5], and therefore axSpA has a large impact on ability
to work, and personal and societal costs are high [6, 7].
Drug treatment and physiotherapy, in particular exer-
cise therapy, are the cornerstones of appropriate man-
agement of the disease [1, 8]. In particular, the fact that
people with axSpA have an increased risk of cardiovas-
cular diseases [9], and evidence shows that axSpA
affects flexibility [10], balance [11], muscle strength [12]
and cardiorespiratory capacity [13], emphasize the need
for exercise. In this respect, it is important to underline
that exercise is a subset of physical activity and is de-
fined as ‘planned, structured and repetitive [activity that]
has as a final or intermediate objective, the improvement
or maintenance of one or more dimensions of physical
activity’ [14, 15]. Therapeutic exercises are individual
and/or disease specific, meant to improve or restore
function or to prevent dysfunction.
Regarding exercise, a Cochrane systematic literature
review [10] showed that exercise interventions have an
effect on spinal mobility and physical function, with the
most favourable results being seen with supervised
group exercise. None of the 11 included studies in that
systematic literature review reported harm as a result of
exercising. Based on this evidence, exercise is generally
recommended in professional guidelines, with the type
(aerobic, muscle strengthening and flexibility) and the
preferred mode of delivery [supervised, group exercise
therapy (GET)] being defined [1, 16, 17]. Recently,
EULAR published recommendations on physical activity
emphasizing the importance of adequate composition
and dosage of activities according to American College
of Sports Medicine (ACSM) principles [15] throughout
the course of disease [18]. Indeed, individual and GET
meeting the frequencies, intensity, time, type, volume,
progression (FITT-VP) principles described by ACSM
[15] was shown to be effective in people with axSpA, by
having a positive impact on disease activity, joint dam-
age and cardiovascular risk factors [19–21]. In addition,
a number of trials investigated the effectiveness of car-
diovascular training on disease activity and cardiovascu-
lar fitness [20–22]. Despite these insights, in research
and daily practice exercise may not meet the require-
ments described in the guidelines. It was found that
only a small proportion of GET evaluated in clinical trials
met the ACSM recommendations for flexibility, muscle
strength or aerobic exercise capacity [23]. Moreover, a
small survey revealed that physiotherapists providing
GET in Switzerland did not include elements of aerobic
training in an adequate dose during the training
sessions in people with axSpA (K.N., unpublished data).
Apart from insufficient delivery, some patients may not
exercise at all. The literature on barriers and facilitators
to engage in exercise in patients with axSpA is, how-
ever, scanty [24].
Internationally, there are currently activities going on
to develop an implementation strategy to optimize the
usage and delivery of physiotherapy and exercise.
Therefore, we aimed to make an inventory of use, expe-
riences and preferences of people with axSpA regarding
the delivery of individual physiotherapy and GET. Given
that usage, content and preferences regarding physio-
therapy may vary among countries, the inventory was
carried out in two countries, The Netherlands (NL) and
Switzerland (CH).
Methods
Design and setting
This cross-sectional survey was conducted among peo-
ple with axSpA living in the western region of NL and
the German-speaking part of CH. The findings are
reported in line with the STrengthening the Reporting of
OBservational studies in Epidemiology (STROBE) guide-
lines [25]. The study obtained ethical approval from the
Leiden University Hospital Ethical committee (P14.326)
and Ethics committee Canton Zurich (KEK-ZH-71–2015).
In both countries, NL and CH, supervised exercise
therapy can be offered on an individual or group basis.
The latter is usually water and/or land based, offered
once a week, supervised by a physical therapist, and
yields an important social factor [26].
The amount of refund for both individual and group
therapy differs between the two countries, because
health insurance systems are different. In NL, direct ac-
cess to physiotherapy was introduced in 2006, and
most health-care insurers reimburse direct access ther-
apy. However, axSpA GET is currently not reimbursed in
NL. In CH, health-care insurers reimburse physiotherapy,
including axSpA group exercise, but only if it is induced
by a referral. In both countries, but based on different
systems, patients have to pay an obligatory financial
contribution. In both countries, health-care insurers have
expressed the need for a proof of the effectiveness of
exercise therapy.
Participants
Dutch patients
Four hundred and fifty-eight people with a confirmed di-
agnosis of axSpA who had visited the rheumatology out-
patient clinic in the past 12 months were identified from
the registries of three hospitals in The Netherlands:
Leiden University Medical Center, Haga Teaching
Hospital, The Hague, and Reinier de Graaf Gasthuis,
Delft. Eligible patients received an invitation letter
from their treating rheumatologist, an information leaflet,
a paper survey and a pre-stamped envelope by regular
mail. Returned questionnaires were scanned and
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analysed with the software Cardiff Software (CA, USA).
No reminders were sent.
Swiss patients
All 1742 German-speaking members of the Schweizerische
Vereinigung Morbus Bechterew (SVMB) were invited
by e-mail to complete an online survey (by use of
SurveyMonkey) or a paper version. Representatives of
SVMB, a rheumatologist and a researcher signed the in-
vitation. Electronic data were collected with the Internet
Protocol (IP) address inactive to preserve anonymity,
and all paper questionnaires were collected by the
SVMB and forwarded as anonymized versions for data
analysis. No reminders were sent.
Assessments
Survey on exercise use and preferences
The survey was self-developed in Dutch by a team of
researchers and, at a later stage, translated into
German. The survey consisted of dichotomous- or
multiple-choice questions, multiple-answer options
(MAOs) and some with a free text field (‘other’ option).
The survey consisted of the following parts:
. Demographic and clinical information: age, sex, disease
duration (in years) and use of medication (pain medica-
tion, NSAIDs, DMARDs, biologics or no drugs; MAO).
. Use of Individual physiotherapy: usage (if ever/cur-
rently, frequency, duration and way of referral) and con-
tents of physiotherapy (active and passive exercises,
home exercises, hydrotherapy, education, massage,
thermotherapy, kinesiotaping, electrotherapy, US, dry
needling, relaxation techniques, either individual or
group setting; by MAO). In addition, if patients had used
physiotherapy but stopped, the reasons for stopping
were queried (too hard, more complaints, motivation,
no positive effect, too time consuming or no refund; by
MAO); Unfortunately, in the online survey for the Swiss
population, the option describing the content of the in-
dividual therapy as ‘I perform exercises meant to
strengthen my muscles by using my own weight or free
weights or machines’ vanished owing to a technical
problem, which led to a bias (is this case, data collec-
tion is based on the free text field option).
. Use of group physiotherapy: usage of land-based or
water-based GET (ever/currently/no; frequency and du-
ration) and, if patients had stopped it, the reasons were
queried (too hard, more discomfort, motivation, no posi-
tive effect, too time consuming or no refund; by MAO).
. Patients’ motivation and preferences regarding exer-
cises: willingness/ability to exercise individually, knowl-
edge of how to exercise without supervision, way of
interaction with supervisior [e.g. (in)direct, via technol-
ogy, group], preferred frequency and duration of orga-
nized activity (by MOA).
Health status
In addition, the Assessment of Spondyloarthritis
International Society Health Index (ASAS-HI) was in-
cluded. This self-reported questionnaire evaluates 17
aspects of function and health and 9 environmental fac-
tors in patients with SpA, providing a score on the
individuals’ health status [27, 28]. The lower the score,
the better the ‘functioning’ [29].
Data analysis
Demographic and disease-specific data were presented
as the mean and S.D. or median and associated range
for continuous data or as frequencies (percentages) for
categorical variables. To compare the characteristics of
Dutch and Swiss patients, Student’s unpaired t-tests or
Mann–Whitney U-tests were used where appropriate for
continuous data, and v2 or Fisher’s exact tests for cate-
gorical data. In addition, logistic regression models with
nationality as an independent variable were fitted to the
data, adjusting for the effect of age, sex, disease dura-
tion, DMARD use and current health status. For some of
these analyses, some levels of the dependent variable
were grouped: current or past treatment by a physical
therapists combined to ‘yes’ vs ‘no treatment’; current
or past use of GET combined to ‘yes’ vs ‘no’; referral by
rheumatologist or referral by general practitioner com-
bined to ‘referral by doctor’ vs ‘direct access’; duration
of treatment >5 years and 1–5 years combined to
‘1 yearþ’ vs <6 months and 6 months to 1 year com-
bined to ‘<1 year’; and frequency of individual therapy
less than once per week and once per week combined
to ‘once’ vs twice or at least three times per week com-
bined to ‘twiceþ’.
The parameters of the logistic regression models are
log odds ratios (LOR): logONL/OCH ¼logONL  logOCH
for the event given by the second level of the outcome
variable, mostly ‘yes’. We reported the exponentiated
values (odds ratios).
The level of significance was set at a¼0.05. The R
language and environment for statistical computing
(http://www.Rproject.org, 2018) was used for the statis-
tical analyses.
Results
Demographics
In total, 713 people participated; 206 in NL (response
rate 45%) and 507 in CH (response rate 29%; 0.5%
used the paper version). Approximately 57% of partici-
pants were male, with a median (range) disease duration
of 16 (1–65) years and median (range) ASAS-HI score of
4.2 (0–14.2). The Dutch cohort was statistically different
with regard to sex, age, disease duration, ASAS-HI
score and the use of pain medication (Table 1).
More than one-third (36.7%) of participants had used
or had been using individual physiotherapy but never
attended a GET, 29.1% had used or had been using a
combination of individual plus land- or water-based
GET, and 5.3% had used or had been using land- and
water-based GET only (see Table 2).
Use of individual physiotherapy
In total, 83.3% of the patients were currently or had
been treated by a physiotherapist individually (1:1)
Axial spondyloarthritis and physiotherapy
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(Table 3). Direct access to physiotherapy was used by
17.1%. However, the chance of being referred to phys-
iotherapy by a general practitioner or rheumatologist, in
contrast to going on ones’ own initiative, was 2.7 times
higher in Switzerland than in NL (adjusted odds ratio
2.74, 95% CI 1.57, 4.83; Table 3).
Regarding individual physiotherapy content (Table 3),
most participants receive a combination of active
(70.4%) or (assisted) passive (75.2%) flexibility interven-
tions, massage (53.6%) and instructions on home exer-
cises (67.7%).
Use of land- or water-based GET
Participants usually met once a week (median 4 times a
month) for 60 min land-based or for 45 min water-based
exercise. The most frequent reason for discontinuation
was ‘too time consuming’ (22.5% for land-based and
22% for water-based GET; Table 4).
Participants’ motivation and preferences regarding
exercise
A large proportion of participants (75.9%) were not
aware of the extra risk of cardiovascular disease and
osteoporosis caused by axSpA (see Table 5). However,
more than two-thirds of the participants were motivated
to carry out exercises to improve fitness (82.7%; see
Table 5). Reasons for being unwilling or unable to exer-
cise were ‘I don’t feel like it’ (44.8%) for being unwilling
and ‘I get more discomfort’ (72%) for being unable
(Supplementary Table S1, available at Rheumatology
Advances in Practice online).
The proportion of the participants who felt self-
responsible and able to conduct an unsupervised pro-
gramme themselves was 42.4%. Of those participants
preferring supervised exercising, 28% liked having an in-
dividual programme with face-to-face supervision by a
physiotherapist (see Table 5). Two-thirds of the partici-
pants (67.9%) preferred the supervising physiotherapist
TABLE 1 Characteristics of Dutch and Swiss people with axial spondyloarthritis participating in a survey on
physiotherapy
Characteristic Total (n5 713) NL (n5 206) CH (n5 507) P-value*
Sex, male, n (%) 404 (56.7) 142 (69.3) 262 (51.7) <0.001
Age, years, median (range) 55.0 (21–94) 58.0 (24–94) 53.5 (21–85) <0.001
Disease duration, years, median (range) 16 (1–65) 24 (1–58) 13 (1–65) <0.001
Current drug treatment
Pain medication (e.g. paracetamol), n (%) 206 (29.0) 82 (39.8) 124 (24.5) <0.001
Anti-inflammatory pain medication
NSAIDs, n (%) 424 (59.5) 125 (60.7) 300 (59.2) 0.73
DMARDs, n (%) 103 (14.7) 25 (12.1) 78 (15.4) 0.26
Biologic, n (%) 270 (38.0) 81 (39.3) 189 (37.3) 0.61
No axSpA-related drugs, n (%) 94 (13.3) 16 (7.8) 78 (15.4) 0.06
ASAS Health Index, median (range) 4.2 (0–14.9) 5.7 (0–14.9) 4.3 (0–14.9) <0.001
*P-value of v2 or Mann–Whitney U-test.
ASAS: Assessment of Spondyloarthritis International Society; axSpA: axial spondyloarthritis; CH: Switzerland; NL: The
Netherlands.
TABLE 2 Use of individual and group exercise therapy by people with axial spondyloarthritis
Setting Total n5713 No (%) NL n5 205a No (%) CH n5 506a No (%)
Individual therapy only 262 (36.7) 102 (49.7) 160 (31.6)
GET only
Land-based GET only 14 (1.9) 3 (1.4) 11 (2.1)
Water-based GET only 3 (0.4) 0 (0) 3 (0.5)
Combination land- and water-based GET 38 (5.3) 5 (2.4) 33 (6.5)
Combination of individual and GET
Combination individual with land-based GET 105 (14.7) 32 (15.6) 73 (14.4)
Combination individual with water-based GET 19 (2.6) 9 (4.3) 10 (1.9)
Combination individual with land and water-based GET 208 (29.1) 37 (18.0) 171 (33.7)
Never used any type of therapy 62 (8.6) 17 (8.8) 45 (8.8)
aOne individual did not answer those questions.
CH: Switzerland; GET: group exercise therapy; NL: the Netherlands.
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TABLE 3 Use and content of individual physiotherapy by Dutch and Swiss people with axial spondyloarthritis
Total NL CH P-value* Adjusted odds
ratio (95% CI)
Current or past individual physiotherapy treatment n 5 713 n 5206 n5 507 Yes vs no Yes vs no
No (%) No (%) No (%)
Currently 233 (32.6) 90 (43.7) 143 (28.2) 0.07 1.41 (0.86, 2.39)
In the past 362 (50.7) 90 (43.7) 272 (53.6)
Never 118 (16.5) 26 (12.0) 92 (18.1)
Referral n 5 437 n 5 169 n5 268 Direct vs referral
No (%) No (%) No (%)
Direct access 75 (17.1) 44 (26.0) 31 (11.6) <0.001 2.74 (1.57, 4.83)
Referral by GP 130 (29.7) 32 (18.9) 98 (36.6)
Referral by rheumatologist or rheumatology
nurse specialist
226 (51.7) 89 (52.7) 137 (51.1)
Other 6 (1.3) 4 (3.4) 2 (0.7)
Duration of treatment n 5 232 n5 89 n5 143 <1 year vs 1 year
No (%) No (%) No (%)
>5 years 132 (56.8) 67 (75.2) 65 (45.5) 0.06 0.57 (0.23, 1.34)
1–5 years 63 (27.1) 13 (14.6) 50 (34.8)
6 months- 1 year 11 (4.7) 4 (4.4) 7 (4.9)
<6 months 26 (11.2) 5 (5.6) 21 (14.7)
Frequency n5230 n5 89 n5 141 Once or less vs
twice or moreNo (%) No (%) No (%)
<1 per week 99 (43.0) 45 (50.5) 54 (38.3) 0.08 0.58 (0.31, 1.06)
Once per week 106 (46.0) 31 (34.8) 75 (53.2)
Twice per week 23 (10.0) 13 (14.6) 10 (7.1)
Three times or more per week 2 (0.8) 0 (0) 2 (1.4)
Content n 5 598 n 5 180 n5 418
No (%) No (%) No (%)
Education
Education on coping with limitations 128 (21.4) 60 (33.3) 68 (16.3) <0.001 2.11 (1.35, 3.27)
Education on sports and physical activity 206 (34.4) 72 (40.0) 134 (32.0) 0.13 1.4 (0.99, 2.19)
Instruction on home exercises 405 (67.7) 121 (67.2) 284 (67.9) 0.51 0.87 (0.58, 1.30)
Exercises
Cardiovascular (aerobic) exercises 105 (17.5) 40 (22.2) 65 (15.6) 0.08 1.26 (0.77, 2.03)
Muscle strengthening exercises 262 (43.8) 76 (42.2) 186 (44.5) 0.93 0.83 (0.56, 1.22)
Active range of motion/flexibility exercises 275 (70.4) 70 (38.8) 205 (49.0) 0.01 0.58 (0.39, 0.85)
Balance exercises 94 (15.7) 31 (17.2) 63 (15.0) 0.62 1.09 (0.64, 1.83)
Relaxation exercises 21 (3.5) 6 (3.3) 15 (3.6) 1.00 0.94 (0.32, 2.45)
Passive range of motion exercises 262 (43.8) 99 (55.0) 163 (38.9) 0.00 2.13 (1.45, 3.15)
Passive assisted range of motion exercises 188 (31.4) 54 (30.0) 134 (32.0) 0.50 0.98 (0.65, 1.46)
Other physiotherapy treatment
Heat treatment 126 (21.0) 17 (9.4) 109 (26.0) <0.001 0.28 (0.15, 0.49)
Cold treatment 13 (2.1) 3 (1.6) 10 (2.4) 0.76 0.61 (0.13, 2.10)
Massage 321 (53.6) 90 (50.0) 231 (55.3) 0.11 0.80 (0.55, 1.18)
Kinesiotaping 64 (10.7) 3 (1.6) 61 (15.1) <0.001 0.14 (0.03, 0.41)
US 97 (16.2) 33 (18.3) 64 (15.3) 0.47 1.19 (0.71, 1.97)
Dry needling 29 (4.8) 6 (3.3) 23 (5.5) 0.30 0.67 (0.23, 1.65)
Reasons for stopping (if applicable) n 5 362 n5 90 n5 272
No (%) No (%) No (%)
Not necessary anymore 73 (20.1) 16 (17.8) 57 (20.9) 0.64 0.70 (0.37, 1.25)
Being able to do the exercises at home 202 (55.8) 52 (57.7) 150 (55.1) 0.10 0.80 (0.53, 1.20)
No perceived effect 75 (20.7) 17 (18.8) 58 (21.3) 0.65 0.66 (0.34, 1.23)
More discomfort 37 (10.2) 12 (13.3) 25 (9.1) 0.32 1.04 (0.456, 2.247)
Inadequate reimbursement (any more) 65 (17.9) 17 (18.8) 48 (17.6) 1.00 0.897 (0.46, 1.65)
Other 59 (16.2) 13 (14.4) 46 (16.9) 0.40 0.41 (0.19, 0.80)
*P-value of Mann–Whitney U, v2 or Fisher’s exact tests.
CH: Switzerland; GET: group exercise therapy; GP ¼ general practitioner; MC: multiple choice; NL: The Netherlands.
Axial spondyloarthritis and physiotherapy
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to be specialized in axSpA (see Table 5), with signifi-
cantly more Swiss than Dutch participants finding this
important. In contrast, 20.2% preferred exercising in a
regular fitness club without specialized supervision. The
ideal organized exercising setting would take place once
per week, for a duration of 1 h, in the evening, but not
at weekends (Table 5).
Discussion
This survey among a sample of people with axSpA
found that physiotherapy was frequently used, in both
individual and GET settings. Individual therapy, mostly
initiated by doctoral referral, was more often used than
GET. The patients in this study seemed to be motivated
to exercise in either a supervised or non-supervised, in-
dividually tailored programme; for both settings, the
majority of patients found that guidance by a specialist
would be required. Currently, individual therapy seemed
to be based on passive interventions combined with
instructions for (home) exercises. If active interventions
were included in the therapy sessions, which appeared
to be the case in <50%, mainly muscle strengthening
and flexibility exercises were used; aerobic exercises
and balance exercises, which are also recommended for
people with axSpA [18], were less often promoted.
Counselling or advice seemed to play only a subsidiary
role.
Recently, a Dutch guideline specific for physiotherapy
in axSpA was launched [30], but given that this guideline
is available only in Dutch, physical therapists may work
according to international general management recom-
mendations for axSpA [1, 17, 31–33] and use experien-
ces from other rheumatic conditions, such as OA [34] or
RA [35]. Some axSpA guidelines clearly state that active
TABLE 4 Use and content of land- or water-based group exercise therapy by Dutch and Swiss patients
Total NL CH P-value* Adjusted odds
ratio (95% CI)
Land-based GET
Current or past land-based GET n 5 712 n5 205 n 5507 Yes vs no Yes vs no
No (%) No (%) No (%)
Currently 171 (24.0) 18 (8.8) 153 (30.2) <0.001 0.28 (0.18, 0.42)
In the past 193 (27.1) 59 (28.8) 134 (26.4)
Never 348 (48.8) 128 (62.4) 220 (43.4)
Frequency per month, n n ¼ 168 n ¼ 18 n ¼ 150
Median (range) 4 (1–10) 4 (1–4) 4 (1–10) 0.95 n.c.
Duration of session, min n ¼ 170 n ¼ 18 n ¼ 152
Median (range) 60 (0–150) 90 (30–150) 60 (20–90) <0.001 n.c.
Reasons for stopping (if applicable, MC) n 5 191 n 5 57 n 5 134
No (%) No (%) No (%)
Too hard 28 (14.6) 17 (29.8) 11 (8.0) <0.001 3.60 (1.42, 9.36)
More discomfort 22 (11.5) 8 (14.0%) 14 (10.3) 0.62 1.28 (0.42, 3.63)
No motivation 37 (19.3) 12 (21.0) 25 (18.4) 0.84 0.94 (0.39, 2.12)
No perceived effect 34 (17.8) 10 (17.5) 24 (17.6) 0.83 0.69 (0.26, 1.69)
Too time consuming 43 (22.5) 10 (17.5) 33 (24.3) 0.25 0.92 (0.36, 2.19)
Inadequate reimbursement (any more) 10 (5.2) 8 (14.0) 2 (1.5) <0.001 13.48 (2.00, 157.03)
Water-based GET
Current or past water-based GET? n 5 712 n5 205 n 5 507 yes vs no yes vs no
No (%) No (%) No (%)
Currently 117 (16.4) 16 (7.8) 101 (19.9) <0.001 0.28 (0.18, 0.43)
In the past 150 (21.0) 34 (16.6) 116 (22.8)
Never 445 (62.5) 155 (75.6) 290 (57.2)
Frequency per month, n n 5 114 n 5 14 n 5 100
Median (range) 4 (1–10) 4 (1–8) 4 (1–10) 0.05 n.c.
Duration of session, min n 5 116 n 5 16 n 5 100
Median (range) 45 (20–135) 45 (30–135) 45 (20–90) 0.38 n.c.
Reasons for stopping water-based GET
(if applicable, MC)
n 5 150 n 5 34 n 5 116
No (%) No (%) No (%)
Too hard 17 (11.3) 9 (26.5) 8 (6.8) <0.001 9.27 (2.57, 39.09)
More discomfort 12 (8.0) 4 (11.7) 8 (6.8) 0.47 2.16 (0.32, 13.53)
No motivation 26 (17.3) 8 (23.5) 18 (15.4) 0.29 2.22 (0.76, 6.31)
No perceived effect 25 (16.6) 11 (32.3) 14 (11.9) <0.001 3.10 (1.09, 8.77)
Too time consuming 33 (22.0) 6 (17.6) 27 (23.0) 0.63 0.81 (0.24, 2.36)
Inadequate reimbursement (any more) 10 (6.6) 5 (14.7) 5 (4.3) 0.04 2.27 (0.42, 10.64)
*P-value of Mann–Whitney U, v2 or Fisher’s exact tests.
CH: Switzerland; GET: group exercise therapy; MC: multiple choice; n.c.: not calculated; NL: The Netherlands.
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TABLE 5 Preferences of people with axial spondyloarthritis for content and design of education and exercise
Knowledge about disease and exercise Total NL CH P-value* Adjusted odds
ratio (95% CI)
Knowledge about how to get information
on axSpA
n 5 651 n 5 153 n 5 498
No (%) No (%) No (%)
Yes 574 (88.1) 121 (79.0) 453 (90.3) <0.001 n.c.
No 77 (11.8) 32 (20.9) 45 (9.0)
Awareness of extra risk of cardiovascular
diseases and osteoporosis
n 5 708 n 5 201 n 5 507
No (%) No (%) No (%)
Yes 161 (22.7) 60 (29.8) 101 (21.7) 0.025 n.c.
No 538 (75.9) 141 (70.1) 397 (78.3)
Willingness to improve fitness n 5 704 n 5 197 n 5 507
No (%) No (%) No (%)
No 49 (6.9) 29 (14.7) 20 (3.9) <0.001 n.c.
Yes, but not able to 72 (10.2) 33 (16.8) 39 (7.7)
Yes, I do my best already 416 (59.0) 93 (47.2) 323 (63.7)
Yes 167 (23.7) 42 (21.3) 125 (24.7)
Preferences for delivery of unsupervised or supervised exercising? (multiple-answer option)
Unsupervised exercises preferred (MC) n 5 685 n 5 199 n 5 486
No (%) No (%) No (%)
General instructions via leaflet or website 128 (18.6) 37 (18.5) 91 (18.7) 0.99 1.05 (0.66, 1.66)
General instructions via DVD or telephone
application
130 (18.9) 34 (17.0) 96 (19.7) 0.84 1.01 (0.62, 1.59)
Personalized programme 250 (36.4) 50 (25.1) 200 (41.1) <0.001 0.62 (0.41, 0.91)
Personal programme with guidance by an
expert by email, Internet or telephone
application
102 (14.8) 20 (10.0) 82 (16.8) 0.02 0.70 (0.39, 1.21)
I am self-responsible and able to conduct
an unsupervised exercise programme
291 (42.4) 71 (35.6) 220 (45.2) 0.02 0.74 (0.51, 1.06)
Supervised exercise preferred (MC) n 5 670 n 5 190 n 5 480
No (%) No (%) No (%)
Individual exercise programme with face-
to-face supervision by physical therapist
188 (28.0) 35 (18.4) 153 (31.2) <0.001 0.60 (0.38, 0.92)
Individual exercise with Internet-based
guidance (e.g. webcam)
57 (8.5) 6 (3.1) 51 (10.6) <0.001 0.32 (0.12, 0.72)
Group exercise programme for axSpA
patients
233 (34.7) 36 (18.9) 197 (41.0) <0.001 0.34 (0.22, 0.52)
Regular sport activities (sport club or fit-
ness centre) supervised by sports
instructor
136 (20.2) 26 (13.6) 110 (22.9) <0.001 0.54 (0.32, 0.87)
Duration per session n 5 445 n 5 90 N5 355
No (%) No (%) No (%)
<1 h 47 (10.3) 11 (12.2) 36 (10.1) n.c. n.c.
1 h 313 (70.3) 50 (55.5) 263 (74.0)
1.5 h 61 (13.7) 17 (18.9) 44 (12.4)
>1.5 h 24 (5.3) 12 (13.3) 12 (3.3)
Frequency per week n 5 440 n 5 85 n 5 355
No (%) No (%) No (%)
Once 239 (54.3) 42 (49.4) 197 (55.5) n.c. n.c.
Twice 151 (34.3) 34 (40.0) 117 (32.9)
Three times 50 (11.3) 7 (8.2) 43 (12.1)
More than three times 9 (2.0) 2 (2.3) 7 (1.9)
Time of the day n 5 503 n 5 84 n 5 419
No (%) No (%) No (%)
Morning 138 (27.4) 27 (32.1) 111 (25.9) n. c. n.c.
Afternoon 61 (12.1) 12 (14.3) 49 (11.4)
Evening 241 (47.9) 35 (41.7) 206 (48.0)
Does not matter 73 (14.5) 10 (11.9) 63 (14.7)
During weekends n 5 440 n 5 84 n 5 356
No (%) No (%) No (%)
Yes 123 (27.9) 27 (32.1) 96 (26.9) n.c. n.c.
No 239 (54.3) 50 (59.5) 189 (53.1)
I don’t know 78 (17.7) 7 (1.2) 71 (19.9)
(continued)
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therapy is more effective than passive therapy [16],
whereas RA recommendations state that passive inter-
ventions may be considered for only a limited period
[35]. Physiotherapy interventions with therapeutic exer-
cises or exercise training should be structured, i.e. in-
corporating goals, a treatment plan and regular
assessments [36]. The patients’ needs and preferences
and the presence of facilitators and barriers regarding
exercising should be taken into account [18]. Known
facilitators are higher education level, belief in the bene-
fits of exercise, and intrinsic motivation, whereas bar-
riers are being physically inactive, fatigue, lack of time
or tiring exercises [37]. Therefore, priority should be
given to patients’ preferences in exercise choice and
conditions. A Cochrane review evaluated the effect of
physiotherapeutic interventions for axSpA, showed that
GET was superior to home exercise [10]. Moreover, a
group setting was found to foster adherence to exercise
[17]. Indeed, the social aspect of GET is well known
(‘moving with friends’) and was also appreciated by the
Dutch and Swiss participants in the survey. However,
group therapy in NL was not as often attended as in CH
(8.8 vs 30.2% were currently attending GET), with the
numbers and sizes of the groups declining, and people
in the groups ageing (oral communication). These obser-
vations could imply that in the future we need to find al-
ternative modes to obtain the added effect of exercising
in a group, e.g. by web-based physiotherapy [38] and
establishment of digital communities. But costs must
also be considered, because GET was not being
refunded fully for many Dutch patients, or its availability
was limited, unlike the situation in CH.
Irrespective of the mode of delivery, it should be en-
sured that the intervention is not underdosed according to
ACSM principles [15]. It must be emphasized that exercis-
ing once per week, i.e. usual frequency of group exercise
interventions, is not enough to fulfil the public health rec-
ommendations for physical activity. In this respect, it is
noteworthy that two-thirds of the participants from both
countries were not aware that regular exercising might
help to reduce the extra risk of cardiovascular diseases.
Although aerobic exercise is highly recommended [39],
this was part of the individual physiotherapeutic interven-
tion in only 17.5% in our study. Unfortunately, we do not
know the extent to which aerobic training was performed
during GET, despite the fact that this setting is ideal to
promote aerobic exercises. With respect to balance exer-
cises, these were reported by only 15.7% of patients, al-
though people with axSpA more often have impaired
balance compared with healthy controls and a higher risk
of falls [11, 40]. Overall, our data underscore that the tradi-
tional focus on strength and flexibility exercises still domi-
nates the physiotherapeutic interventions for people with
axSpA and that consideration of cardiovascular and neu-
romotor exercises should be emphasized. Recalling the
afore-mentioned multiplicity of physical activity recommen-
dations, we believe that people with axSpA need more
guidance to fulfil every aspect (i.e. cardiovascular, muscle
strength, balance and flexibility training). Future physiother-
apy interventions should be based on physical activity rec-
ommendations in addition to patients’ needs.
Regarding the patient perspective on the delivery of
exercise interventions in axSpA in both countries, 67.9%
of the sample thought that it is ‘important’ and ‘very im-
portant’ that the supervising physical therapist is spe-
cialized in their condition (i.e. a specialization in
rheumatic conditions/axSpA was more valued than a
specialization in sports). This finding clearly underpins
the need for the specialized physical therapist.
A large proportion of the people participating in the sur-
vey in both countries signalled awareness of self-
responsibility to exercise, in particular in a non-supervised
setting but with tailored instructions. It should also be
noted that 42.4% preferred unsupervised (non-GET set-
ting) exercise. This need requires interventions to counsel
and help a patient managing axSpA ‘from a distance’. For
this purpose, physical therapists’ knowledge and skills re-
garding counselling strategies and long-term exercise pro-
motion need to be evaluated and, presumably, improved.
Findings showed that 21% of the Dutch and 9% of the
Swiss population surveyed did not know how to find infor-
mation about their condition (Table 5). Physiotherapists
also bear responsibility in providing information and sup-
port in disease management.
TABLE 5 Continued
Knowledge about disease and exercise Total NL CH P-value* Adjusted odds
ratio (95% CI)
Supervisor should be expert in n 5 439 n 5 85 n 5 354
No (%) No (%) No (%)
Sports 76 (17.3) 24 (28.2) 52 (14.7) <0.001 n.c.
Bone and joints 115 (26.1) 29 (34.1) 86 (24.3) 0.07 n.c.
Bone and joints and rheumatic diseases 368 (83.8) 62 (72.9) 306 (86.4) <0.001 n.c.
How important is it that supervising physi-
cal therapist is expert specifically in
axSpA?
n 5 515 n 5 159 n 5 356
No (%) No (%) No (%)
(Very) important 350 (67.9) 83 (55.7) 267 (75.0) <0.001 0.43 (0.28, 0.67)
Not important 165 (32.0) 76 (44.3) 89 (25.0)
*P-value of Mann–Whitney U-test, v2 test or Fisher’s exact test.
axSpA: axial spondyloarthritis; CH: Switzerland; MC: multiple choice; n.c.: not calculated; NL: The Netherlands.
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Limitations
This study has a number of limitations. One limitation
was that the selection of patients was different in NL
and CH, which might explain some of the differences
observed between the two groups. Another limitation
was that the survey questionnaire was self-developed,
and we did not ask for the content of group exercise
interventions, because it was assumed that standard
programmes would be used.
In addition, the process of data collection differed be-
tween countries (i.e. paper vs online-survey and one
question being posted differently). Nevertheless, we be-
lieve a comparison between the two nations is still use-
ful to appraise common and different issues.
Concerning the reported differences between NL and
CH in terms of the use and preferences of people with
axSpA related to exercising, the comparisons were ad-
justed for potential confounders, such as differences in
case mix or settings. However, we cannot rule out the
possibility that there were other factors influencing the
observed differences in habits and attitudes towards
exercising.
Further research should assess the perspective of
physical therapists of the content and structure of inter-
ventions in people with axSpA. Guidelines for the physi-
otherapeutic management of people with axSpA,
including recommendations on (long-term) exercise pro-
motion, in addition to an implementation strategy for
both nations, are needed urgently.
Conclusions
Exercises are a commonly used intervention in people
with axSpA, in both the individual and the group setting.
There is an international need for implementing active
exercises at appropriate doses, especially with more fo-
cus on cardiovascular exercising in the individual or
GET setting. Our findings may help to develop further
the patient-centred services independent of insurance
systems. In particular, enabling people with axSpA to
perform exercises independently would meet their needs
and might enhance their daily physical activity.
Acknowledgements
F.G. and T.P.M.V.V. initiated the project. F.G. developed
the questionnaire BEVER and edited the Dutch data.
A.-K.R.O. translated the questionnaire into German,
edited the Swiss data and performed the data analysis.
B.W. organized the data collection in Switzerland;
F.A.G., Y.P.M.G.-R. and A.J.P. organized the data col-
lection in The Netherlands. T.P.M.V.V. and K.N. were in-
volved in the study conceptualization and supervised
the study process. A.M. conducted the logistic regres-
sion analyses. A.-K.R.O. drafted the manuscript, and all
authors reviewed it, provided comments on each draft
and approved the final version. We would like to thank
Rene´ Braem (CEO Swiss Ankylosing Spondylitis
Association) for supporting the survey among SVMB
members, and Markus Ernst (ZHAW) for supporting the
progress of the manuscript.
Funding: The development of the questionnaire was
financially supported by the Dutch Arthritis Foundation
(ReumaNederland; formerly named Reumafonds),
Amsterdam (Project number: BP 14-1-161).
Disclosure statement: The authors declare no conflict of
interest.
Supplementary data
Supplementary data are available at Rheumatology
Advances in Practice online.
References
1 van der Heijde D, Ramiro S, Landewe´ R et al. 2016
update of the ASAS-EULAR management recommenda-
tions for axial spondyloarthritis. Ann Rheum Dis 2017;76:
978–91.
2 Bohn R, Cooney M, Deodhar A, Curtis JR, Golembesky
A. Incidence and prevalence of axial spondyloarthritis:
methodologic challenges and gaps in the literature. Clin
Exp Rheumatol 2018;36:263–74.
3 Hamilton L, Macgregor A, Toms A et al. The prevalence
of axial spondyloarthritis in the UK: a cross-sectional co-
hort study. BMC Musculoskelet Disord 2015;16:392.
4 Rusman T, van Vollenhoven RF, van der Horst-Bruinsma
IE. Gender differences in axial spondyloarthritis: women
are not so lucky. Curr Rheumatol Rep 2018;20:35.
5 Braun J, Sieper J. Ankylosing spondylitis. Lancet 2007;
369:1379–90.
6 Ramonda R, Marchesoni A, Carletto A et al. Patient-reported
impact of spondyloarthritis on work disability and working
life: the ATLANTIS survey. Arthritis Res Ther 2016;18:78.
7 Strand V, Singh JA. Patient burden of axial
spondyloarthritis. J Clin Rheumatol 2017;23:383–91.
8 Noureldin B, Barkham N. The current standard of care
and the unmet needs for axial spondyloarthritis.
Rheumatology 2018;57:vi10–7.
9 Mathieu S, Gossec L, Dougados M, Soubrier M.
Cardiovascular profile in ankylosing spondylitis: a
systematic review and meta-analysis. Arthritis Care Res
2011;63:557–63.
10 Dagfinrud H, Kvien TK, Hagen KB. Physiotherapy
interventions for ankylosing spondylitis. Cochrane
Database Syst Rev 2008;CD002822.
11 Dursun N, Sarkaya S, Ozdolap S et al. Risk of falls in
patients with ankylosing spondylitis. J Clin Rheumatol
2015;21:76–80.
12 Sahin N, Ozcan E, Baskent A, Karan A, Kasikcioglu E.
Muscular kinetics and fatigue evaluation of knee using
by isokinetic dynamometer in patients with ankylosing
spondylitis. Acta Reumatol Port 2011;36:252–9.
13 Peters MJ, Visman I, Nielen MM et al. Ankylosing
spondylitis: a risk factor for myocardial infarction? Ann
Rheum Dis 2010;69:579–81.
Axial spondyloarthritis and physiotherapy
https://academic.oup.com/rheumap 9
D
ow
nloaded from
 https://academ
ic.oup.com
/rheum
ap/article-abstract/3/2/rkz043/5588853 by Zurich U
niv Applied Sciences user on 06 January 2020
14 Caspersen CJ, Powell KE, Christenson GM. Physical
activity, exercise, and physical fitness: definitions and
distinctions for health-related research. Public Health
Rep 1985;100:126–31.
15 Garber CE, Blissmer B, Deschenes MR et al. American
College of Sports Medicine position stand. Quantity and
quality of exercise for developing and maintaining
cardiorespiratory, musculoskeletal, and neuromotor fitness
in apparently healthy adults: guidance for prescribing
exercise. Med Sci Sports Exerc 2011;43:1334–59.
16 Ward MM, Deodhar A, Akl EA et al. American College of
Rheumatology/Spondylitis Association of America/
Spondyloarthritis Research and Treatment Network 2015
Recommendations for the treatment of ankylosing
spondylitis and nonradiographic axial spondyloarthritis.
Arthritis Rheumatol 2016;68:282–98.
17 Millner JR, Barron JS, Beinke KM et al. Exercise for
ankylosing spondylitis: an evidence-based consensus
statement. Semin Arthritis Rheum 2016;45:411–27.
18 Rausch Osthoff AK, Niedermann K, Braun J et al. 2018
EULAR recommendations for physical activity in people
with inflammatory arthritis and osteoarthritis. Ann Rheum
Dis 2018;77:1251–60.
19 Sveaas SH, Smedslund G, Hagen KB, Dagfinrud H.
Effect of cardiorespiratory and strength exercises on
disease activity in patients with inflammatory rheumatic
diseases: a systematic review and meta-analysis. Br J
Sports Med 2017;51:1065–72.
20 Sveaas SH, Berg IJ, Provan SA et al. Efficacy of high
intensity exercise on disease activity and cardiovascular
risk in active axial spondyloarthritis: a randomized
controlled pilot study. PLoS One 2014;9:e108688.
21 Niedermann K, Sidelnikov E, Muggli C et al. Effect of
cardiovascular training on fitness and perceived disease
activity in people with ankylosing spondylitis. Arthritis
Care Res 2013;65:1844–52.
22 Berg IJ, van der Heijde D, Dagfinrud H et al. Disease
activity in ankylosing spondylitis and associations to
markers of vascular pathology and traditional
cardiovascular disease risk factors: a cross-sectional
study. J Rheumatol 2015;42:645–53.
23 Dagfinrud H, Halvorsen S, Vøllestad NK et al. Exercise
programs in trials for patients with ankylosing
spondylitis: do they really have the potential for
effectiveness? Arthritis Care Res 2011;63:597–603.
24 Niedermann K, Nast I, Ciurea A, Vliet Vlieland T, van
Bodegom-Vos L. Barriers and facilitators of vigorous
cardiorespiratory training in axial spondyloarthritis:
surveys among patients, physiotherapists,
rheumatologists. Arthritis Care Res 2019;71:839–51.
25 von Elm E, Altman DG, Egger M et al. The Strengthening
the Reporting of Observational Studies in Epidemiology
(STROBE) statement: guidelines for reporting
observational studies. J Clin Epidemiol 2008;61:344–9.
26 Demmelmaier I, Lindkvist A, Nordgren B, Opava CH. “A
gift from heaven” or “This was not for me”. A mixed
methods approach to describe experiences of
participation in an outsourced physical activity program
for persons with rheumatoid arthritis. Clin Rheumatol
2015;34:429–39.
27 Kiltz U, van der Heijde D, Boonen A et al. Development
of a health index in patients with ankylosing spondylitis
(ASAS HI): final result of a global initiative based on the
ICF guided by ASAS. Ann Rheum Dis 2015;74:830–5.
28 SpondyloArthritis international Society. https://www.
asas-group.org/clinical-instruments/asas-health-index/
(21 May 2018, date last accessed).
29 Kiltz U, van der Heijde D, Boonen A, Braun J. The ASAS
Health Index (ASAS HI) – a new tool to assess the health
status of patients with spondyloarthritis. Clin Exp
Rheumatol 2014;32:S-105–8.
30 van Weely SFE, Van der Giesen FJ, van Gaalen F et al.
Aanbevelingen voor fysiotherapie bij mensen met axiale
spondyloartritis. https://www.nhpr.nl/wp-content/
uploads/2019/05/Aanbevelingen-voor-fysiotherapie-
axiale-SpA-2018.pdf: KNGF; 2018 (30 March 2019, date
last accessed).
31 Ozgocmen S, Akgul O, Altay Z et al. Expert opinion and
key recommendations for the physical therapy and
rehabilitation of patients with ankylosing spondylitis. Int J
Rheum Dis 2012;15:229–38.
32 Wendling D, Lukas C, Paccou J et al. Recommendations
of the French Society for Rheumatology (SFR) on the
everyday management of patients with spondylarthritis.
Joint Bone Spine 2014;81:6–14.
33 Braun J, van den Berg R, Baraliakos X et al. 2010
update of the ASAS/EULAR recommendations for the
management of ankylosing spondylitis. Ann Rheum Dis
2011;70:896–904.
34 Zhang W, Moskowitz RW, Nuki G et al. OARSI
recommendations for the management of hip and knee
osteoarthritis, Part II: OARSI evidence-based, expert con-
sensus guidelines. Osteoarthritis Cartilage 2008;16:137–62.
35 Hurkmans EJ, Van der Giesen FJ, Bloo H et al. Therapy
RDSfP. KNGF-Guideline for Physical Therapy in patients
with rheumatoid arthritis. Practice Guidelines 2008.
https://www.kngf.nl/binaries/content/assets/kennisplat
form/onbeveiligd/guidelines/rheumatoid_arthritis_practice_
guidelines_2008.pdf (2 August 2015, date last accessed).
36 WCPT. WCPT guideline for standards in physical therapy
practice. 2011. In: WCPT, ed. http://www.wcpt.org/
guidelines/standards (14 February 2018, date last
accessed).
37 Fongen C, Sveaas SH, Dagfinrud H. Barriers and
facilitators for being physically active in patients with
ankylosing spondylitis: a cross-sectional comparative
study. Musculoskel Care 2015;13:76–83.
38 Paul L, McDonald MT, Coulter E et al. Adherence to
web-based physiotherapy in people with axial spondy-
loarthrtis. Rheumatology 2019;58(Suppl_3), kez107.084,
https://doi.org/10.1093/rheumatology/kez107.084.
39 Agca R, Heslinga SC, Rollefstad S et al. EULAR
recommendations for cardiovascular disease risk
management in patients with rheumatoid arthritis and
other forms of inflammatory joint disorders: 2015/2016
update. Ann Rheum Dis 2017;76:17–28.
40 Murray HC, Elliott C, Barton SE, Murray A. Do patients
with ankylosing spondylitis have poorer balance than
normal subjects? Rheumatology 2000;39:497–500.
Anne-Kathrin Rausch Osthoff et al.
10 https://academic.oup.com/rheumap
D
ow
nloaded from
 https://academ
ic.oup.com
/rheum
ap/article-abstract/3/2/rkz043/5588853 by Zurich U
niv Applied Sciences user on 06 January 2020
